Reid Merryman, MD clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   Epco, Zanu, Ritux for R/R FL or MZL

   Primary completion pushed from Mar 1, 2028 to Mar 1, 2030

   Also in this update: Primary endpoint(s) modified; Enrollment increased: 45 → 71 participants

   Reid Merryman, MD·Phase 2· NCT06563596· Registry history of NCT06563596 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.